pfizer
More Posts on pfizer
Merck Says Antiviral Pill for COVID-19 Is Effective, Plans to File for Emergency Authorization
The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a planned interim analysis of the trial.
Merck Says Experimental Covid-19 Pill Cuts Risk of Death by 50%
If approved, the drug would be the first pill effective against Covid-19.
More Than 30 Companies, Including Amazon, Facebook and Pfizer Vow to Create Economic Opportunities for Afghan Refugees
The 34 companies have joined the Tent Coalition for Afghan Refugees, which aims to integrate Afghan refugees into the United States.
Pfizer Says its COVID-19 Vaccine is Safe and Likely to Work In Younger Children, and it's Planning to Ask for Permission to Use it In Kids as Young as 5
The pharmaceutical giant plans to soon apply for an expanded OK that includes 5- to 11-year-olds.
Pfizer Says COVID-19 Vaccine Efficacy Weakens Over Time
Pfizer said that booster doses should be given to all people aged 16 and older six months after they received their second dose of the mRNA vaccine.
First Patient Gets Dose in Pfizer's Oral COVID-19 Drug Trial
"If successful, we believe this therapy could help reduce severity of illness among a broad population of patients," Rod MacKenzie, Pfizer's chief development officer, said in a statement.
Vaccine-Maker BioNTech Sees 2nd-Quarter Profits Soar
In an earnings report released on Monday, the Mainz-based company said that it made a net profit of nearly $3.3 billion between April and June.
3 Vaccine Stocks to Buy Now
While Moderna (NASDAQ:MRNA) has been the king of vaccine stocks and is getting added to the S&P 500, there are other names that present a better risk-...
The Top 3 Stocks Under $50 to Buy Now
They aren’t quite as volatile as penny stocks and can end up being some of the best bargains in the market. Let’s take a look at the top 3 stocks under $50 to buy now.
Pfizer Submits Application Requesting Full Approval From FDA for Its Covid-19 Vaccine
Pfizer has initiated the process of seeking full FDA approval for its Covid-19 vaccine.
Pfizer Vaccine to Be Approved for 12- to 15-Year-Olds
The FDA will authorize the use of the Pfizer Covid-19 vaccine in teens, as the U.S. moves forward to vaccinate other age groups.
One Dose of Pfizer or AstraZeneca Vaccine Can Slow Covid-19 Spread in a Household by About 50%, Study Reveals
Public Health England expects a similar result in places with high transmission risks, such as prisons.